{"id":"https://openalex.org/W2336682121","doi":null,"title":"Intangible-Specific Non-Financial Disclosures and Cost of Capital: Evidence from the U.S. Pharmaceutical Industry","display_name":"Intangible-Specific Non-Financial Disclosures and Cost of Capital: Evidence from the U.S. Pharmaceutical Industry","alternate_titles":[],"publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2336682121","mag":"2336682121"},"language":"en","primary_location":{"id":"mag:2336682121","doi":null,"is_oa":true,"landing_page_url":"https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID2767449_code1299323.pdf?abstractid=2767449&mirid=1","pdf_url":null,"source":{"id":"https://openalex.org/S4210172589","display_name":"SSRN Electronic Journal","issn_l":"1556-5068","issn":["1556-5068"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1318003438","host_organization_name":"RELX Group (Netherlands)","host_organization_lineage":["https://openalex.org/I1318003438"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"SSRN Electronic Journal","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2336682121"],"child_works_count":0,"type":"preprint","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID2767449_code1299323.pdf?abstractid=2767449&mirid=1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027677256","display_name":"Shibashish Mukherjee","orcid":"https://orcid.org/0000-0002-4382-7572","observed_orcids":["https://orcid.org/0000-0002-4382-7572"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Shibashish Mukherjee","raw_affiliation_strings":["University of Groningen"],"raw_orcid":"https://orcid.org/0000-0002-4382-7572","affiliations":[{"raw_affiliation_string":"University of Groningen","institution_ids":["https://openalex.org/I169381384"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5027677256"],"corresponding_institution_ids":["https://openalex.org/I169381384"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11849","display_name":"Intellectual Capital and Performance Analysis","score":0.47780001163482666,"subfield":{"id":"https://openalex.org/subfields/1408","display_name":"Strategy and Management"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11849","display_name":"Intellectual Capital and Performance Analysis","score":0.47780001163482666,"subfield":{"id":"https://openalex.org/subfields/1408","display_name":"Strategy and Management"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10115","display_name":"Corporate Social Responsibility Reporting","score":0.32519999146461487,"subfield":{"id":"https://openalex.org/subfields/1408","display_name":"Strategy and Management"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10081","display_name":"Auditing, Earnings Management, Governance","score":0.15209999680519104,"subfield":{"id":"https://openalex.org/subfields/1402","display_name":"Accounting"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intangible-assets","display_name":"intangible assets","score":0.8799999952316284},{"id":"https://openalex.org/keywords/non-financial-reporting","display_name":"non-financial reporting","score":0.9169999957084656},{"id":"https://openalex.org/keywords/textual-disclosure","display_name":"textual disclosure","score":0.7490000128746033},{"id":"https://openalex.org/keywords/cost-of-capital","display_name":"cost of capital","score":0.9369999766349792},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.9419999718666077},{"id":"https://openalex.org/keywords/management-s-discussion-and-analysis","display_name":"management discussion and analysis","score":0.8009999990463257},{"id":"https://openalex.org/keywords/expected-stock-returns","display_name":"expected stock returns","score":0.7960000038146973},{"id":"https://openalex.org/keywords/intellectual-property","display_name":"intellectual property","score":0.6869999766349792},{"id":"https://openalex.org/keywords/innovation-disclosure","display_name":"innovation disclosure","score":0.7580000162124634},{"id":"https://openalex.org/keywords/information-disclosure-quality","display_name":"disclosure quality","score":0.7110000252723694}],"concepts":[{"id":"https://openalex.org/C2777402642","wikidata":"https://www.wikidata.org/wiki/Q2557224","display_name":"Explanatory power","level":2,"score":0.7155594825744629},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.5994823575019836},{"id":"https://openalex.org/C204036174","wikidata":"https://www.wikidata.org/wiki/Q909380","display_name":"Stock (firearms)","level":2,"score":0.5050602555274963},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.48330047726631165},{"id":"https://openalex.org/C2780838347","wikidata":"https://www.wikidata.org/wiki/Q1329252","display_name":"Intellectual capital","level":2,"score":0.4755786955356598},{"id":"https://openalex.org/C121955636","wikidata":"https://www.wikidata.org/wiki/Q4116214","display_name":"Accounting","level":1,"score":0.47355547547340393},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.435769259929657},{"id":"https://openalex.org/C2776943663","wikidata":"https://www.wikidata.org/wiki/Q165687","display_name":"Human capital","level":2,"score":0.4239363372325897},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.33117952942848206},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.27039873600006104},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2336682121","doi":null,"is_oa":true,"landing_page_url":"https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID2767449_code1299323.pdf?abstractid=2767449&mirid=1","pdf_url":null,"source":{"id":"https://openalex.org/S4210172589","display_name":"SSRN Electronic Journal","issn_l":"1556-5068","issn":["1556-5068"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1318003438","host_organization_name":"RELX Group (Netherlands)","host_organization_lineage":["https://openalex.org/I1318003438"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"SSRN Electronic Journal","raw_type":null}],"best_oa_location":{"id":"mag:2336682121","doi":null,"is_oa":true,"landing_page_url":"https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID2767449_code1299323.pdf?abstractid=2767449&mirid=1","pdf_url":null,"source":{"id":"https://openalex.org/S4210172589","display_name":"SSRN Electronic Journal","issn_l":"1556-5068","issn":["1556-5068"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1318003438","host_organization_name":"RELX Group (Netherlands)","host_organization_lineage":["https://openalex.org/I1318003438"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"SSRN Electronic Journal","raw_type":null},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W153123102","https://openalex.org/W1564392604","https://openalex.org/W1967287237","https://openalex.org/W1992222839","https://openalex.org/W2117142123","https://openalex.org/W2140358882","https://openalex.org/W2144947169","https://openalex.org/W2170522129","https://openalex.org/W2263256921","https://openalex.org/W2323989283","https://openalex.org/W3121350720","https://openalex.org/W3121627204","https://openalex.org/W3121783211","https://openalex.org/W3123237382","https://openalex.org/W3123817661","https://openalex.org/W3123826726","https://openalex.org/W3124301289","https://openalex.org/W3124423437","https://openalex.org/W3124536214","https://openalex.org/W3125512896","https://openalex.org/W4388169679"],"related_works":["https://openalex.org/W4385062809","https://openalex.org/W6908903777","https://openalex.org/W6986879931","https://openalex.org/W1978777690","https://openalex.org/W4416919744","https://openalex.org/W7155221748","https://openalex.org/W4289743148","https://openalex.org/W3122861422","https://openalex.org/W7099209594","https://openalex.org/W1506518806"],"abstract_inverted_index":{"This":[0],"paper":[1],"studies":[2],"the":[3,6,15,28,36,39,63,77,100],"impact":[4],"of":[5,21,49,54,109,113],"forward":[7],"looking":[8],"intangibles-specific":[9,64],"non-financial":[10,65],"and":[11,51,66,92],"textual":[12,67],"disclosures":[13],"on":[14],"annual":[16,40],"reports":[17,41],"(including":[18],"MD&A,":[19],"etc.)":[20,87],"25":[22],"biggest":[23],"Pharmaceutical":[24],"firms":[25],"listed":[26],"in":[27],"United":[29],"States.":[30],"Using":[31],"a":[32,107,110],"mixed":[33],"research":[34],"method":[35],"information":[37,68,78],"from":[38,57],"are":[42,96],"categorized":[43],"into":[44,81],"two":[45],"sections,":[46],"(i.)":[47],"\u2018existence":[48],"disclosure\u2019,":[50],"(ii.)":[52],"\u2018quality":[53],"disclosure.\u2019":[55],"Evidence":[56],"this":[58],"study":[59],"shows":[60],"that,":[61],"overall,":[62],"does":[69],"not":[70],"have":[71],"any":[72],"explanatory":[73],"power.":[74],"However,":[75],"when":[76],"is":[79,106],"sub-divided":[80],"communication":[82],"types":[83],"(Strategy,":[84],"Human":[85],"Resources,":[86],"then":[88],"Customer":[89],"&":[90,94],"Market":[91],"Innovation":[93],"IPR":[95],"found":[97],"to":[98],"explain":[99],"expected":[101],"stock":[102],"returns":[103],"\u2014":[104],"which":[105],"measure":[108],"firm\u2019s":[111],"cost":[112],"capital.":[114]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2336682121","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
